147 related articles for article (PubMed ID: 6423880)
1. [8-hydroxyquinoline derivatives as wide-spectrum chemotherapeutic agents].
Chernomordik AB
Klin Med (Mosk); 1984 Feb; 62(2):133-6. PubMed ID: 6423880
[No Abstract] [Full Text] [Related]
2. [5-Nok in the treatment of candidiasis].
Ljubojević S; Perinović M; Kesić V
Med Arh; 1975; 29(6):643-4. PubMed ID: 814373
[No Abstract] [Full Text] [Related]
3. [1st experiences with 5-nitro-oxyquinoline in the treatment of chronic urinary tract infection].
Schlesinger E; Patsch R; Kraft M
Z Urol Nephrol; 1975 Jun; 70(6):429-34. PubMed ID: 810992
[No Abstract] [Full Text] [Related]
4. [Effectiveness of intestopan and other etiotropic agents in acute dysentery].
Chaĭtsev VG; Chechel'nitskiĭ VM; Terent'ev VF
Sov Med; 1977 Nov; (11):149-51. PubMed ID: 415374
[No Abstract] [Full Text] [Related]
5. [8-Hydroxyquinoline derivatives in the treatment of patients with onychomycoses].
Butareva TA; Kukushkin AM; Unzhakov VP; Nemkaeva RM
Vestn Dermatol Venerol; 1986; (12):50-3. PubMed ID: 2951932
[No Abstract] [Full Text] [Related]
6. [Effect of a corticosteroid additive on the result of local therapy of bacterial superinfection in tinea pedis intertriginosa].
Gründer K; Petzoldt D
Hautarzt; 1979 Jul; 30(7):392-5. PubMed ID: 113370
[TBL] [Abstract][Full Text] [Related]
7. [Experience in using new drug preparations for treating adult patients with acute intestinal infections].
Mashilov VP; Avdeeva LA; Kaluzhina TI; Brodov LE; Golokhvastova EL; Iakovleva ON; Alikeeva GK
Ter Arkh; 1990; 62(1):89-92. PubMed ID: 2110389
[TBL] [Abstract][Full Text] [Related]
8. Results obtained in Intestopan treatment of patients with dysenteric syndrome (adult patients).
Münnich D; Bakondi M
Ther Hung; 1975; 23(2):77-80. PubMed ID: 810910
[No Abstract] [Full Text] [Related]
9. Comparative study of the efficacy of chloramphenicol and a combination of chloramphenicol, broxyquinoline and brobanzoxaldine in the treatment of enteric fever.
Edibam BM
Indian Pediatr; 1975 Jul; 12(7):587-91. PubMed ID: 810421
[No Abstract] [Full Text] [Related]
10. [A new antifungal agent based on hydroxyquinoline].
Knapp A; Haufe U; Haufe F; Schwenke W
Dermatol Monatsschr; 1977 Jun; 163(6):471-7. PubMed ID: 409624
[No Abstract] [Full Text] [Related]
11. [Indices for the user of halogenized 8-hydroxyquinolines in dermatology].
Levkov AA; Dubiaga AN
Vestn Dermatol Venerol; 1977 Feb; (2):69-72. PubMed ID: 404774
[No Abstract] [Full Text] [Related]
12. [Treatment of skin tissue losses of different etiologies with 8-oxyquinoline associated with local anesthetics].
Passarino M; Bogetti P; Lo Presti F; Perla A; Casale A; Giachero E; Anfossi G
Minerva Chir; 1983 Jul 15-31; 38(13-14):1113-9. PubMed ID: 6415546
[No Abstract] [Full Text] [Related]
13. [Therapeutic experience with 5-chloro-8-hydroxyquinoline].
Gärtner R; Kaben U
Dermatol Monatsschr; 1977 Sep; 163(9):711-4. PubMed ID: 411692
[TBL] [Abstract][Full Text] [Related]
14. [Allergies to 8-hydroxyquinoline derivatives].
Hutzler D; Pevny I
Derm Beruf Umwelt; 1988; 36(3):86-90. PubMed ID: 2970376
[TBL] [Abstract][Full Text] [Related]
15. The halogenated 8-hydroxyquinolines.
Neldner KH
Int J Dermatol; 1977 May; 16(4):267-73. PubMed ID: 140848
[No Abstract] [Full Text] [Related]
16. [Advances in pharmacokinetic studies and clinical use of antibiotics and various chemotherapeutic agents in children].
Prandota J; Sarul H
Pediatr Pol; 1988 Jun; 63(6):397-404. PubMed ID: 3070476
[No Abstract] [Full Text] [Related]
17. [Experience with the preparation 5-NOK in a clinical trial. I. Microbiological investigation (author's transl].
Hausnerová S; Tesarová Z; Uhlír O
Cesk Epidemiol Mikrobiol Imunol; 1975 Mar; 24(2):97-101. PubMed ID: 124227
[No Abstract] [Full Text] [Related]
18. [Oxyquinoline derivatives for peroral use will disappear from the market].
Pedersen A
Ugeskr Laeger; 1978 May; 140(20):1181. PubMed ID: 664065
[No Abstract] [Full Text] [Related]
19. [Dangerous side effects of 8-hydroxyquinoline?].
Hautarzt; 1990 Apr; 41(4):243-4. PubMed ID: 2113514
[No Abstract] [Full Text] [Related]
20. [Treatment of lower genital infections with a benzydamine-hydroxyquinoline combination].
Maritati V; Soro E; Tanganelli E
Minerva Ginecol; 1987 Mar; 39(3):185-8. PubMed ID: 3601189
[No Abstract] [Full Text] [Related]
[Next] [New Search]